Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysis

The authors aimed to analyze the discrepancies among major colchicine trials (COLCOT, LoDoCo2, and CLEAR SYNERGY) in terms of their effectiveness for cardiovascular prevention, particularly focusing on how the designation of an outlier trial changes based on assumed treatment effects. Their descriptive analysis revealed that the trial considered least compatible with the overall treatment effect varied depending on the assumed benefit, suggesting that CLEAR SYNERGY's neutral outcome cannot be simply labeled as an outlier without considering these assumptions. The study highlights the complexity of interpreting trial results and the influence of underlying assumptions on perceived efficacy.